YANDEX NV-A (YNDX) Fundamental Analysis & Valuation

NASDAQ:YNDX • NL0009805522

Current stock price

18.94 USD
-1.38 (-6.79%)
At close:
14.9 USD
-4.04 (-21.33%)
Pre-Market:

This YNDX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. YNDX Profitability Analysis

1.1 Basic Checks

  • YNDX had positive earnings in the past year.
YNDX Yearly Net Income VS EBIT VS OCF VS FCFYNDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 20B -20B 40B

1.2 Ratios

Industry RankSector Rank
ROA -3.05%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
YNDX Yearly ROA, ROE, ROICYNDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 10 20

1.3 Margins

Industry RankSector Rank
OM -3.95%
PM (TTM) -4.41%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
YNDX Yearly Profit, Operating, Gross MarginsYNDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 40 60

2

2. YNDX Health Analysis

2.1 Basic Checks

  • YNDX has more shares outstanding than it did 1 year ago.
  • YNDX has a worse debt/assets ratio than last year.
YNDX Yearly Shares OutstandingYNDX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 100M 200M 300M
YNDX Yearly Total Debt VS Total AssetsYNDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 100B 200B 300B 400B 500B

2.2 Solvency

  • An Altman-Z score of 2.48 indicates that YNDX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • YNDX has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Altman-Z 2.48
ROIC/WACCN/A
WACCN/A
YNDX Yearly LT Debt VS Equity VS FCFYNDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 100B 200B 300B

2.3 Liquidity

  • YNDX has a Current Ratio of 1.80. This is a normal value and indicates that YNDX is financially healthy and should not expect problems in meeting its short term obligations.
  • A Quick Ratio of 1.71 indicates that YNDX should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.71
YNDX Yearly Current Assets VS Current LiabilitesYNDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50B 100B 150B 200B 250B

8

3. YNDX Growth Analysis

3.1 Past

  • YNDX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -161.87%.
  • YNDX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.56% yearly.
  • YNDX shows a strong growth in Revenue. In the last year, the Revenue has grown by 63.12%.
  • The Revenue has been growing by 36.22% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-161.87%
EPS 3Y-22.57%
EPS 5Y-13.56%
EPS Q2Q%-55.63%
Revenue 1Y (TTM)63.12%
Revenue growth 3Y40.78%
Revenue growth 5Y36.22%
Sales Q2Q%54.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 151.57% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, YNDX will show a very strong growth in Revenue. The Revenue will grow by 35.03% on average per year.
EPS Next Y277.45%
EPS Next 2Y181.57%
EPS Next 3Y160.33%
EPS Next 5Y151.57%
Revenue Next Year37.74%
Revenue Next 2Y35.69%
Revenue Next 3Y34.8%
Revenue Next 5Y35.03%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
YNDX Yearly Revenue VS EstimatesYNDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B 800B 1T
YNDX Yearly EPS VS EstimatesYNDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200 400 600 800

2

4. YNDX Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 78.92, the valuation of YNDX can be described as expensive.
  • Compared to an average S&P500 Price/Earnings ratio of 27.42, YNDX is valued quite expensively.
  • A Price/Forward Earnings ratio of 20.58 indicates a rather expensive valuation of YNDX.
  • YNDX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.24.
Industry RankSector Rank
PE 78.92
Fwd PE 20.58
YNDX Price Earnings VS Forward Price EarningsYNDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.75
YNDX Per share dataYNDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as YNDX's earnings are expected to grow with 160.33% in the coming years.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y181.57%
EPS Next 3Y160.33%

0

5. YNDX Dividend Analysis

5.1 Amount

  • YNDX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

YNDX Fundamentals: All Metrics, Ratios and Statistics

YANDEX NV-A

NASDAQ:YNDX (2/25/2022, 8:19:56 PM)

Premarket: 14.9 -4.04 (-21.33%)

18.94

-1.38 (-6.79%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)N/A
Earnings (Next)04-27
Inst Owners14.85%
Inst Owner Change-24.71%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.79B
Revenue(TTM)356.17B
Net Income(TTM)-15.71B
Analysts83.2
Price Target85.82 (353.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 78.92
Fwd PE 20.58
P/S 1.57
P/FCF N/A
P/OCF N/A
P/B 2.17
P/tB N/A
EV/EBITDA 33.75
EPS(TTM)0.24
EY1.27%
EPS(NY)0.92
Fwd EY4.86%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.04
BVpS8.72
TBVpSN/A
PEG (NY)0.28
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -3.05%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -3.95%
PM (TTM) -4.41%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.71
Altman-Z 2.48
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-161.87%
EPS 3Y-22.57%
EPS 5Y-13.56%
EPS Q2Q%-55.63%
EPS Next Y277.45%
EPS Next 2Y181.57%
EPS Next 3Y160.33%
EPS Next 5Y151.57%
Revenue 1Y (TTM)63.12%
Revenue growth 3Y40.78%
Revenue growth 5Y36.22%
Sales Q2Q%54.09%
Revenue Next Year37.74%
Revenue Next 2Y35.69%
Revenue Next 3Y34.8%
Revenue Next 5Y35.03%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

YANDEX NV-A / YNDX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for YANDEX NV-A?

ChartMill assigns a fundamental rating of 4 / 10 to YNDX.


Can you provide the valuation status for YANDEX NV-A?

ChartMill assigns a valuation rating of 3 / 10 to YANDEX NV-A (YNDX). This can be considered as Overvalued.


What is the profitability of YNDX stock?

YANDEX NV-A (YNDX) has a profitability rating of 3 / 10.


What is the valuation of YANDEX NV-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for YANDEX NV-A (YNDX) is 78.92 and the Price/Book (PB) ratio is 2.17.


Can you provide the expected EPS growth for YNDX stock?

The Earnings per Share (EPS) of YANDEX NV-A (YNDX) is expected to grow by 277.45% in the next year.